跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30 条关于
“Napi2b”
全部
30
临床试验
13
药物
9
机构
2
资讯
6
10个月前
Tubulis Secures $361M Series C to Advance NaPi2b-Targeting ADC for Ovarian Cancer and Lung Adenocarcinoma
12个月前
Tubulis Reports Promising Phase I/IIa Data for TUB-040 ADC in Platinum-Resistant Ovarian Cancer
2年前
FDA Clears IND Application for Zymeworks' Novel FRα-Targeted ADC, ZW191
去年
Tubulis and Bristol Myers Squibb Advance First Collaborative Tubutecan ADC into Clinical Trials
上个月
ArriVent Advances Firmonertinib Toward Pivotal EGFR Exon 20 NSCLC Data as ADC Pipeline Progresses
10个月前
Day One Biopharmaceuticals Acquires Mersana Therapeutics for $129M, Targeting Rare Cancer Treatment